Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP809359.RATL-q4VD0mIGljxPyHkPwvmdOQ39AJ9MVMEbetH0gSkU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP809359.RATL-q4VD0mIGljxPyHkPwvmdOQ39AJ9MVMEbetH0gSkU130_assertion type Assertion NP809359.RATL-q4VD0mIGljxPyHkPwvmdOQ39AJ9MVMEbetH0gSkU130_head.
- NP809359.RATL-q4VD0mIGljxPyHkPwvmdOQ39AJ9MVMEbetH0gSkU130_assertion description "[These data suggest that pharmacological reversal of VDR methylation may re-establish breast cancer cell susceptibility to differentiation therapy using Calcitriol.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP809359.RATL-q4VD0mIGljxPyHkPwvmdOQ39AJ9MVMEbetH0gSkU130_provenance.
- NP809359.RATL-q4VD0mIGljxPyHkPwvmdOQ39AJ9MVMEbetH0gSkU130_assertion evidence source_evidence_literature NP809359.RATL-q4VD0mIGljxPyHkPwvmdOQ39AJ9MVMEbetH0gSkU130_provenance.
- NP809359.RATL-q4VD0mIGljxPyHkPwvmdOQ39AJ9MVMEbetH0gSkU130_assertion SIO_000772 20431345 NP809359.RATL-q4VD0mIGljxPyHkPwvmdOQ39AJ9MVMEbetH0gSkU130_provenance.
- NP809359.RATL-q4VD0mIGljxPyHkPwvmdOQ39AJ9MVMEbetH0gSkU130_assertion wasDerivedFrom befree-2016 NP809359.RATL-q4VD0mIGljxPyHkPwvmdOQ39AJ9MVMEbetH0gSkU130_provenance.
- NP809359.RATL-q4VD0mIGljxPyHkPwvmdOQ39AJ9MVMEbetH0gSkU130_assertion wasGeneratedBy ECO_0000203 NP809359.RATL-q4VD0mIGljxPyHkPwvmdOQ39AJ9MVMEbetH0gSkU130_provenance.